Lofibra 200 mg Gate 324 Pill - orange capsule/oblong, 19mm

Generic Name: fenofibrate

Pill with imprint Lofibra 200 mg Gate 324 is Orange, Capsule/Oblong and has been identified as Lofibra 200 mg. It is supplied by Gate Pharmaceuticals.

Lofibra is used in the treatment of Hypertriglyceridemia; Hyperlipoproteinemia Type IIa, Elevated LDL; Hyperlipoproteinemia; Hyperlipoproteinemia Type IV, Elevated VLDL; Hyperlipoproteinemia Type IIb, Elevated LDL VLDL and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Lofibra 200 mg Gate 324

Lofibra

Generic Name: fenofibrate
Imprint: Lofibra 200 mg Gate 324
Strength: 200 mg
Color: Orange
Size: 19.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Fibric acid derivatives
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Gate Pharmaceuticals
National Drug Code (NDC): 57844-0324 (Discontinued)
Inactive Ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone k25, corn starch, sodium lauryl sulfate, magnesium silicate, FD&C Red No. 40, D&C Red No. 28, ferric oxide yellow, titanium dioxide
Note: Inactive ingredients may vary.